|Security||EDGE / Edge Therapeutics, Inc.|
|Institution||Bank Of Montreal /can/|
Bank Of Montreal /can/ closes position in EDGE / Edge Therapeutics, Inc.
April 13, 2018 - Bank Of Montreal /can/ has filed a 13F-HR form disclosing ownership of 0 shares of Edge Therapeutics, Inc. (NASDAQ:EDGE) with total holdings valued at $0 USD as of March 31, 2018. Bank Of Montreal /can/ had filed a previous 13F-HR on January 16, 2018 disclosing 1,000 shares of Edge Therapeutics, Inc. at a value of $9,000 USD. This represents a change in shares of -100.00 percent and a change in value of -100.00 percent during the quarter.
Edge Therapeutics, Inc. has declared a standard industrial code (sic) of 2834 which is the "Pharmaceutical Preparations" industry. Bank Of Montreal /can/'s top industries are "Agriculture production livestock and animal specialties" (sic 02), "Legal Services" (sic 81), and "Social Services" (sic 83).
The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.
In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.
Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.
as of ET